[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615000":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":7,"locations":13,"responsibleParty":31,"collaborators":33,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":38,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":15,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Elisa Ciceri","Fondazione IRCCS Istituto Neurologico Carlo Besta","PRINCIPAL_INVESTIGATOR",[14],{"facility":11,"status":15,"city":16,"state":7,"zip":7,"country":17,"countryCode":18,"cosmosGeoPoint":19,"geoPoint":24,"contacts":25},"RECRUITING","Milan","Italy","IT",{"type":20,"coordinates":21},"Point",[22,23],12.59836,42.78235,{"lat":23,"lon":22},[26],{"name":27,"role":28,"phone":29,"phoneExt":7,"email":30},"Elisa Ciceri, MD","CONTACT","+ 39 02.2394","elisa.ciceri@istituto-besta.it",{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[34],{"name":35,"class":6},"Federico II University","100615000","fluorescence-enhanced-stereotactic-surgery-fess-100615000",false,"NCT07286903","Fluorescence Enhanced Stereotactic Surgery (FESS)","Fluorescence Enhanced Stereotactic Surgery","FESS","Inclusion Criteria:\n\n* Patient aged 18 years or older\n* Patients able to provide the informed consentPresumptive diagnosis of high grade glioma\n* Patient whose surgery require the use of 5-ALA as standard of treatment\n\nExclusion Criteria:\n\n* Patients who are not suitable for surgery\n* Patients unable to provide informed consent due to cognitive impairment or other reasons","ALL","18 Years",{"count":47,"type":48},20,"ESTIMATED","OBSERVATIONAL","Histopathological diagnosis is essential for gliomas, but stereotactic biopsy carries significant risks and can fail to provide diagnostic tissue. This study aims to develop and validate an advanced fiber optic system integrated into a standard Nashold biopsy needle. This system combines 5-ALA fluorescence, Raman spectroscopy, and ultrasound imaging to provide real-time feedback on tumor tissue and blood vessels. The study involves ex-vivo testing on brain tumor tissues (High Grade Glioma) obtained through surgical resection to validate the system's ability to identify tumor margins and vascular structures, aiming to improve biopsy safety and accuracy.",[52,53],"High Grade Glioma","High Grade Glioma (III or IV)",[55,56,57,58,59,60,61],"Stereotactic Biopsy","Fluorescence Guided Surgery","5-ALA","Raman Spectroscopy","Glioma","Fiber Opticts","Nashold Needle","2025-12-03",{"date":64,"type":65},"2025-12-16","ACTUAL",{"date":67,"type":65},"2024-07-01",{"date":69,"type":48},"2026-12",{"name":5,"class":6},1]